The results based on CGGA-693 revealed that WHO grade (p < 0.0001), SP1 (p = 0.006), PTEN (p < 0.0001), IDH mutation (p < 0.0001), and chemotherapy (p = 0.004) are independent prognostic factors for glioma (Table 3. This evidence concerns the gene SP1 and central nervous system cancer.